budesonide | 			
Pulmicort | 
				
Rhinocort | 			
Entocort | 
				
51333-22-3 | 			
Preferid | 
				
Rhinocort Aqua | 			
Entocort EC | 
				
Pulmicort Respules | 			
Budesonidum | 
				
Uceris | 			
Budeson | 
				
Pulmicort Flexhaler | 			
Cortivent | 
				
Micronyl | 			
Respules | 
				
Spirocort | 			
Bidien | 
				
S-1320 | 			
CHEBI:3207 | 
				
MAP-0010 | 			
51372-29-3 | 
				
MLS000028507 | 			
Budesonide MMX | 
				
Rhinocort alpha | 			
(R)-Budesonide | 
				
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione | 			
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione | 
				
Budenofalk | 			
Budesonido | 
				
SMR000058337 | 			
Budecort Inhaler | 
				
(+)-16alpha,17alpha-Butylidenedioxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione | 			
16A(R),17-(BUTYLIDENEBIS(OXY))-11B,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE | 
				
Budesonidum INN-Latin | 			
Budesonido INN-Spanish | 
				
Inflammide | 			
Budiair | 
				
Miflonide | 			
Pulmaxan | 
				
Fvolir | 			
Budesonide USAN:INN:BAN:JAN | 
				
Rhinocort Allergy | 			
Pulmaxan turbohaler | 
				
Pulmicort (TN) | 			
Pulmicort Topinasal | 
				
Rhinocort (TN) | 			
Pulmicort turbuhaler | 
				
Budesonide Easyhaler | 			
S 1320 | 
				
CCRIS 5230 | 			
Entocort EC (TN) | 
				
SR-01000000101 | 			
EINECS 257-139-7 | 
				
Jorveza | 			
Eltair | 
				
Ultesa | 			
Noex | 
				
Giona Easyhaler | 			
16?,17-(1RS)-Butylidenebis(oxy)-11?,21-dihydroxypregna-1,4-diene-3,20-dione | 
				
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11.beta.,16.alpha.)- | 			
Prestwick_840 | 
				
MFCD00083259 | 			
Uceris (TN) | 
				
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione | 			
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione | 
				
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde | 			
Budesonide, >=99% | 
				
Opera_ID_1696 | 			
Prestwick0_000518 | 
				
Prestwick1_000518 | 			
Prestwick2_000518 | 
				
Prestwick3_000518 | 			
Epitope ID:161750 | 
				
B 7777 | 			
SCHEMBL4096 | 
				
CHEMBL1370 | 			
Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)- | 
				
Lopac0_000174 | 			
BSPBio_000475 | 
				
Budesonide (JAN/USP/INN) | 			
MLS001077323 | 
				
MLS002207112 | 			
SPBio_002396 | 
				
BPBio1_000523 | 			
GTPL7434 | 
				
DTXSID8020202 | 			
HSDB 8279 | 
				
MAP0010 | 			
R01AD05 | 
				
HMS1569H17 | 			
HMS2096H17 | 
				
HMS2232D17 | 			
HMS3259H07 | 
				
HMS3260D09 | 			
HMS3413B08 | 
				
HMS3413P17 | 			
HMS3677B08 | 
				
HMS3677P17 | 			
HMS3713H17 | 
				
ACT03247 | 			
BCP05589 | 
				
Eohilia (budesonide oral suspension) | 			
Tox21_500174 | 
				
BDBM50354850 | 			
AKOS015969655 | 
				
AC-4697 | 			
ACN-043365 | 
				
CCG-204269 | 			
CS-2063 | 
				
DB01222 | 			
KS-1162 | 
				
LP00174 | 			
NC00626 | 
				
NSC 757788 | 			
SDCCGSBI-0050162.P002 | 
				
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione | 			
NCGC00021318-05 | 
				
NCGC00021318-06 | 			
NCGC00021318-08 | 
				
NCGC00021318-18 | 			
NCGC00089747-04 | 
				
NCGC00260859-01 | 			
BB164267 | 
				
Budesonide 100 microg/mL in Acetonitrile | 			
CPD000058337 | 
				
HY-13580 | 			
Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)- | 
				
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione | 			
B3909 | 
				
EU-0100174 | 			
5301-EP2270008A1 | 
				
5301-EP2280006A1 | 			
5301-EP2281563A1 | 
				
5301-EP2281813A1 | 			
5301-EP2281815A1 | 
				
5301-EP2281819A1 | 			
5301-EP2292617A1 | 
				
5301-EP2292619A1 | 			
5301-EP2295402A2 | 
				
5301-EP2295408A1 | 			
5301-EP2301933A1 | 
				
5301-EP2305640A2 | 			
5301-EP2305659A1 | 
				
5301-EP2308562A2 | 			
5301-EP2311818A1 | 
				
5301-EP2311827A1 | 			
5301-EP2314590A1 | 
				
5301-EP2316459A1 | 			
5301-EP2371811A2 | 
				
D00246 | 			
T70986 | 
				
333B223 | 			
Q422212 | 
				
J-504150 | 			
Q-101375 | 
				
SR-01000000101-2 | 			
SR-01000000101-6 | 
				
BRD-A34299591-001-03-4 | 			
Budesonide, European Pharmacopoeia (EP) Reference Standard | 
				
Budesonide, United States Pharmacopeia (USP) Reference Standard | 			
Budesonide, Pharmaceutical Secondary Standard; Certified Reference Material | 
				
(11?,16?)-16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione | 			
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo10.8.0.0^{2,9}.0^{4,8}.0^{13,18}icosa-14,17-dien-16-one | 
				
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho2,1:4,5indeno1,2-d1,3dioxol-2-one" | 			
(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho2,1:4,5indeno1,2-d1,3dioxol-4-one" | 
				
(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho2,1:4,5indeno1,2-d1,3dioxol-4(2H)-one" | 			
 |